CeriBell, Inc. Debt Securities, Available-for-sale, Amortized Cost
CeriBell, Inc. (CBLL) had Debt Securities, Available-for-sale, Amortized Cost of $96.69 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-10
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $96.69M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $95.91M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $118.63M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $144.66M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $96.69M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $95.91M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $118.63M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $144.66M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $137.28M 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |